Walmart to Join Nasdaq-100 Index as It Replaces AstraZeneca Following Exchange Move 
SK Hynix Shares Hit Record High as AI Memory Demand Fuels Semiconductor Rally 
Hanwha Ocean Shares Rise on Plans to Expand U.S. Shipbuilding Capacity 
Samsung Forecasts Strong Q4 Profit on AI-Driven Memory Chip Boom 
GM Takes $6 Billion EV Write-Down as Electric Vehicle Demand Slows in the U.S. 
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan 
Chevron Sees Path to Boost Venezuela Oil Output by 50% After Trump Administration Talks 
Supreme Court to Hear Cisco Appeal on Alien Tort Statute and Human Rights Liability 
Aktis Oncology Prices Upsized IPO at $18, Raising $318 Million in Major Biotech Debut 
FTC Blocks Edwards Lifesciences’ JenaValve Acquisition in Major Antitrust Ruling 
EU Orders Elon Musk’s X to Preserve Grok AI Data Amid Probe Into Illegal Content 
UBS Upgrades L’Oréal to Buy, Sees Strong Sales Momentum and 20% Upside 
Johnson & Johnson Secures Tariff Exemption by Agreeing to Lower Drug Prices in the U.S. 
Trump Calls for 10% Credit Card Interest Rate Cap Starting 2026 
Ford Targets Level 3 Autonomous Driving by 2028 with New EV Platform and AI Innovations 
OpenAI Sets $50 Billion Stock Grant Pool, Boosting Employee Equity and Valuation Outlook 
BlueScope Steel Shares Slip After Board Rejects A$13.2 Billion Takeover Bid 
SAN FRANCISCO, March 17, 2017 -- BioQ Pharma Incorporated, a specialty pharmaceutical company, announced today that the Company will be presenting at the 27th Annual Oppenheimer Healthcare Conference to be held in New York City on March 21st and 22nd, 2017.
Josh Kriesel, President and Chief Executive Officer, is scheduled to present on Wednesday, March 22nd at 2:45 p.m. Eastern Daylight Time.
About BioQ Pharma
BioQ Pharma Incorporated is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Cipla, Lee's Pharm, Lunatus, Galen Limited, and West Pharmaceutical Services.
Company Contact Information: Josh Kriesel President and CEO +1-415-336-6496 Ron Pauli Chief Financial Officer +1-415-889-7707 Media: Stephanie Carrington Integrated Corporate Relations, Inc. (ICR) +1-646-277-1282
